Acer Therapeutics Inc (ACER) stock has risen 66.27% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ACER stock a score of 85 out of a possible 100.
That rank is mainly influenced by a fundamental score of 97. In addition to the average rating from Wall Street analysts, ACER stock has a mean target price of 10. This means analysts expect the stock to rise 135.85% over the next 12 months. ACER's rank also includes a long-term technical score of 88. The short-term technical score for ACER is 69.
What's Happening with ACER Stock Today
Acer Therapeutics Inc (ACER) stock has risen 6.41% while the S&P 500 has fallen -0.01% as of 2:14 PM on Tuesday, Aug 4. ACER has risen $0.26 from the previous closing price of $3.98 on volume of 772,027 shares. Over the past year the S&P 500 is higher by 15.81% while ACER has risen 66.27%. ACER lost -$2.62 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Acer Therapeutics Inc (ACER) Stock.
